Physician profile
Jeremiah E Juson
NPI 1265766315
$4,793.78
in general payments reported to CMS, 2019-2025
11 companies · $561 in 2025
The $561 reported for 2025 was more than what 82% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $180 · 2021: $290 · 2022: $651 · 2023: $1,434 · 2024: $97.74 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439 · Travel and Lodging: $580 · Education: $70.00 · Gift: $4.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.79 |
| Travel and Lodging | $579.68 |
| Education | $70.00 |
| Gift | $4.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,023.39 | 2019-2025 | Invisalign |
| Ormco Corporation | $1,961.88 | 2019-2023 | Spark |
| Dental Monitoring Sas | $236.81 | 2025 | |
| American Orthodontics Corporation | $215.04 | 2022-2023 | LP and Ifit Tubes, Master Series, Empower-Metal |
| USA Angelalign Technology Corp | $134.72 | 2024-2025 | |
| Ortho Organizers, INC. | $92.07 | 2019-2024 | Carriere |
| Envista Holdings Corporation | $41.85 | 2024-2025 | Damon, Spark |
| Nobel Biocare USA | $37.69 | 2023 | Nobelactive |
| 3m Company | $19.28 | 2021 | |
| World Class Technology Corporation | $17.02 | 2021 | |
| Philips North America LLC | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Juson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.